HORNBILL: a phase I/IIa trial examining the safety, tolerability and early response of BI 764524 in patients with diabetic retinopathy and diabetic macular ischaemia—rationale, study design and protocol

Peer Review reports

Original Submission
14 Dec 2021	Submitted	Original manuscript
21 Jan 2022	Reviewed	Reviewer Report - Kirsty Loudon
27 Mar 2022	Reviewed	Reviewer Report - Ann Margret Ervin
5 Jun 2022	Author responded	Author comments - Victor Chong
Resubmission - Version 2
5 Jun 2022	Submitted	Manuscript version 2
16 Jun 2022	Reviewed	Reviewer Report - Kirsty Loudon
19 Jun 2022	Reviewed	Reviewer Report - Ann Margret Ervin
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
6 Jul 2022	Editorially accepted
17 Aug 2022	Article published	10.1186/s13063-022-06527-y

Back to article page